Dashboard
Manage Tickers

ENTA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

enanta-pharma-q4-eps-087-beats-103-estimate-sales-15125m-miss-15956m-estimate
Enanta Pharma Q4 EPS $(0.87) Beats $(1.03)...
11/17/2025 21:02:30

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of $(1.03)...

earnings-scheduled-for-november-17-2025
Earnings Scheduled For November 17, 2025
11/17/2025 11:11:09

enanta-pharmas-earnings-a-preview
Enanta Pharma's Earnings: A Preview
11/14/2025 14:02:33

this-microsoft-analyst-begins-coverage-on-a-bullish-note-here-are-top-3-initiations-for-friday
This Microsoft Analyst Begins Coverage On ...
11/14/2025 13:29:58

jp-morgan-initiates-coverage-on-enanta-pharma-with-overweight-rating-announces-price-target-of-17
JP Morgan Initiates Coverage On Enanta Pha...
11/14/2025 12:28:56

JP Morgan analyst Anupam Rama initiates coverage on Enanta Pharma (NASDAQ:ENTA) with a Overweight rating and announces Price...

enanta-pharmaceuticals-highlights-promising-zelicapavir-pediatric-results-and-edp-323-post-exposure-prophylaxis-data-for-rsv-at-idweek-2025
Enanta Pharmaceuticals Highlights Promisin...
10/20/2025 11:04:06

Zelicapavir Results in Shortened Symptom Duration in Pediatric PatientsEDP-323 is Highly Effective in a Post-Exposure Prophylax...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 21:06:04

enanta-pharmaceuticals-to-showcase-rsv-drug-data-at-idweek-2025-highlighting-two-oral-once-daily-treatments
Enanta Pharmaceuticals to Showcase RSV Dru...
10/07/2025 11:14:53

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, small molecule ...

jefferies-upgrades-enanta-pharma-to-buy-raises-price-target-to-20
Jefferies Upgrades Enanta Pharma to Buy, R...
10/01/2025 16:27:48

Jefferies analyst Akash Tewari upgrades Enanta Pharma (NASDAQ:ENTA) from Hold to Buy and raises the price target from $14 to...

cal-maine-foods-posts-downbeat-earnings-joins-enanta-pharmaceuticals-aar-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Cal-Maine Foods Posts Downbeat Earnings, J...
10/01/2025 12:16:06

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 12:09:24

why-ryvyl-shares-are-trading-higher-by-97-here-are-20-stocks-moving-premarket
Why Ryvyl Shares Are Trading Higher By 97%...
10/01/2025 09:45:27

reported-earlier-enanta-pharmaceuticals-prices-upsized-public-offering-of-65m-common-shares-at-1000-each-targeting-65m-gross-proceeds
Reported Earlier, Enanta Pharmaceuticals P...
10/01/2025 05:57:38

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 21:06:48

enanta-pharma-commences-50m-public-offering-with-option-to-sell-additional-75m-in-common-stock
Enanta Pharma Commences $50M Public Offeri...
09/30/2025 20:13:18

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs f...

westpark-capital-maintains-buy-on-enanta-pharma-raises-price-target-to-28
WestPark Capital Maintains Buy on Enanta P...
09/30/2025 12:01:09

WestPark Capital analyst Ed Arce maintains Enanta Pharma (NASDAQ:ENTA) with a Buy and raises the price target from $24 to $28.

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

enantas-rsv-pill-shows-promise-in-cutting-recovery-time-for-high-risk-adults
Enanta's RSV Pill Shows Promise In Cutting...
09/29/2025 17:28:46

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpati...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
09/29/2025 17:06:50

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

enanta-pharma-reports-topline-data-from-rsvhr-phase-2b-study-to-evaluate-efficacy-and-safety-of-zelicapavir-in-outpatient-adults-with-acute-rsv-infection
Enanta Pharma Reports Topline Data From RS...
09/29/2025 10:33:28

6.7-Day Improvement in Time to Complete Resolution of All RSV Symptoms for Patients with Chronic Obstructive Pulmonary Disease ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION